Particle Health has responded to Epic Systems’ motion to dismiss its antitrust complaint, alleging Epic is unlawfully eliminating competition in the payer-platform market. Epic denies wrongdoing, arguing the lawsuit is retaliation for protecting patient privacy. Particle claims Epic used illegal tactics to undermine its business, while Epic maintains that the allegations are baseless and harmful to patient data integrity.
Bill would expand access to digital therapeutics
Sens. Capito and Shaheen reintroduced the Access to Prescription Digital Therapeutics Act of 2023, aiming to expand access to FDA-approved software treatments for Medicare patients.
